目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Technology
1.2.3. Distribution Channel
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Technology outlook
2.2.3. Distribution channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Personalized Cancer Vaccine Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Advances in genomic and immunotherapy technologies
3.4.2. Rising cancer prevalence and demand for targeted treatments
3.4.3. Collaborations and increased investment in cancer immunotherapy
3.5. Market Restraint Analysis
3.5.1. High development and manufacturing costs
3.5.2. Regulatory and logistical challenges
3.5.3. Porter’s Five Forces Analysis
3.5.4. PESTEL Analysis

Chapter 4. Personalized Cancer Vaccine Market: Type Estimates & Trend Analysis
4.1. Personalized Cancer Vaccine Market: Type Movement Analysis
4.2. Personalized Cancer Vaccine Market Estimates and Forecast, by Type
4.3. Dendritic Cell
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. RNA-Based (mRNA)
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Neoantigen-Based
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Tumor-Associated Antigen (TAA) Vaccines
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Personalized Cancer Vaccine Market: Technology Movement Analysis
4.8. Personalized Cancer Vaccine Market Estimates and Forecast, by Technology
4.9. Cell-based
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. mRNA PCV
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Personalized Cancer Vaccine Market: Distribution Channel Estimates & Trend Analysis
5.1. Personalized Cancer Vaccine Market: Distribution Movement Analysis
5.2. Personalized Cancer Vaccine Market Estimates and Forecast, by Distribution Channel
5.3. Hospitals
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Clinics
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Research & Academic Institutes
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Personalized Cancer Vaccine Market: Regional Estimates & Trend Analysis
6.1. Personalized Cancer Vaccine Market Share By Region, 2024 & 2030
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Regional Market Dashboard
6.4. Global Regional Market Snapshot
6.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. North America Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.6.2. U.S.
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. U.S. Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.6.3. Canada
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Canada Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.6.4. Mexico
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Mexico Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7. Europe
6.7.1. Europe Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.2. UK
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. UK Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.3. Germany
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Germany Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.4. France
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. France Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.5. Italy
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Italy Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.6. Spain
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Spain Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.7. Denmark
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Denmark Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.8. Sweden
6.7.8.1. Key Country Dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory Framework
6.7.8.4. Sweden Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.7.9. Norway
6.7.9.1. Key Country Dynamics
6.7.9.2. Competitive Scenario
6.7.9.3. Regulatory Framework
6.7.9.4. Norway Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8. Asia Pacific
6.8.1. Asia Pacific Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.2. Japan
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Japan Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.3. China
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. China Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.4. India
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. India Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.5. Australia
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Australia Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.6. Thailand
6.8.6.1. Key Country Dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory Framework
6.8.6.4. Thailand Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.8.7. South Korea
6.8.7.1. Key Country Dynamics
6.8.7.2. Competitive Scenario
6.8.7.3. Regulatory Framework
6.8.7.4. South Korea Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.9. Latin America
6.9.1. Latin America Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.9.2. Brazil
6.9.2.1. Key Country Dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory Framework
6.9.2.4. Brazil Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.9.3. Argentina
6.9.3.1. Key Country Dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory Framework
6.9.3.4. Argentina Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.10. MEA
6.10.1. MEA Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.10.2. South Africa
6.10.2.1. Key Country Dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory Framework
6.10.2.4. South Africa Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.10.3. Saudi Arabia
6.10.3.1. Key Country Dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory Framework
6.10.3.4. Saudi Arabia Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.10.4. UAE
6.10.4.1. Key Country Dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory Framework
6.10.4.4. UAE Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
6.10.5. Kuwait
6.10.5.1. Key Country Dynamics
6.10.5.2. Competitive Scenario
6.10.5.3. Regulatory Framework
6.10.5.4. Kuwait Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Strategy Mapping
7.4. Company Market Share Analysis, 2024
7.5. Company Profiles
7.5.1. Dendreon Pharmaceuticals, LLC
7.5.1.1. Overview
7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Gritstone Bio
7.5.2.1. Overview
7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. CureVac
7.5.3.1. Overview
7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. NeoCura & Innovent
7.5.4.1. Overview
7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Stemirna Therapeutics
7.5.5.1. Overview
7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Elicio Therapeutics
7.5.6.1. Overview
7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Evaxion Biotech
7.5.7.1. Overview
7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Imugene
7.5.8.1. Overview
7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Nouscom
7.5.9.1. Overview
7.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives

List of Tables
Table 1 List of abbreviations
Table 2 Global Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 3 Global Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 4 Global Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 5 Global Personalized Cancer Vaccine Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Personalized Cancer Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 8 North America Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 9 North America Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 11 U.S. Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 12 U.S. Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 14 Canada Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 15 Canada Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Mexico Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 17 Mexico Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 18 Mexico Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Europe Personalized Cancer Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 21 Europe America Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 22 Europe America Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 UK Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 24 UK Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 25 UK Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Germany Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 27 Germany Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 28 Germany Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 France Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 30 France Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 31 France Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 33 Italy Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 34 Italy Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Spain Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 36 Spain Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 37 Spain Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Denmark Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 39 Denmark Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 40 Denmark Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Sweden Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 42 Sweden Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 43 Sweden Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Norway Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 45 Norway Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 46 Norway Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Personalized Cancer Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Japan Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 52 Japan Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Japan Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 China Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 55 China Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 56 China Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 India Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 58 India Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 59 India Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Australia Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 61 Australia Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 62 Australia Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Thailand Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 64 Thailand Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 65 Thailand Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 South Korea Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 67 South Korea Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 68 South Korea Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Latin America Personalized Cancer Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 71 Latin America Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 72 Latin America Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Brazil Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 74 Brazil Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 75 Brazil Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 77 Argentina Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 78 Argentina Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Personalized Cancer Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Personalized Cancer Vaccine Market, by type, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 83 South Africa Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 84 South Africa Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 85 South Africa Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 88 audi Arabia Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 89 UAE Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 90 UAE Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 91 UAE Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Kuwait Personalized Cancer Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 93 Kuwait Personalized Cancer Vaccine Market, by Technology, 2018 - 2030 (USD Million)
Table 94 Kuwait Personalized Cancer Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Personalized Cancer Vaccine Market segmentation
Fig. 8 Market snapshot, 2024
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Personalized cancer vaccine market: Type movement analysis
Fig. 15 Personalized cancer vaccine market: Type outlook and key takeaways
Fig. 16 Dendritic Cell market estimates and forecast, 2018 - 2030
Fig. 17 RNA-Based (mRNA) market estimates and forecast, 2018 - 2030
Fig. 18 Neoantigen-based market estimates and forecast, 2018 - 2030
Fig. 19 Tumor-Associated Antigen (TAA) vaccines market estimates and forecast, 2018 - 2030
Fig. 20 Personalized cancer vaccine market: Technology movement analysis
Fig. 21 Personalized cancer vaccine market: Technology outlook and key takeaways
Fig. 22 Cell-based market estimates and forecast, 2018 - 2030
Fig. 23 mRNA PCV market estimates and forecast, 2018 - 2030
Fig. 24 Others market estimates and forecast, 2018 - 2030
Fig. 25 Personalized cancer vaccine market: Distribution channel movement analysis
Fig. 26 Personalized cancer vaccine market: Distribution channel outlook and key takeaways
Fig. 27 Hospitals market estimates and forecast, 2018 - 2030
Fig. 28 Clinics market estimates and forecast, 2018 - 2030
Fig. 29 Research & academic institutes market estimates and forecast, 2018 - 2030
Fig. 30 Government suppliers market estimates and forecast, 2018 - 2030
Fig. 31 Regional outlook, 2024 & 2030
Fig. 32 Global Personalized Cancer Vaccine Market: Region movement analysis
Fig. 33 North America Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 36 Mexico Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 37 Europe Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 38 Germany Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 39 UK Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 40 France Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 41 Italy Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 42 Spain Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 43 Denmark Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 44 Sweden Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 45 Norway Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 47 Japan Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 48 China Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 49 India Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 50 Australia Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 51 South Korea Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 52 Thailand Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 53 Latin America Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 54 Brazil Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 55 Argentina Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 57 South Africa Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 59 UAE Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)
Fig. 60 Kuwait Personalized Cancer Vaccine Market, 2018 - 2030 (USD Million)